TNFRSF8 and anaplastic large cell lymphoma: Breast implant-associated anaplastic large cell lymphoma (BI-ALCL) is a newly described CD30+ lymphoproliferation with characteristic clinical pathological findings that recently has been incorporated into the 2016 revised WHO classification as a provisional entity [1].